Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Retraction: Carnosol, a Constituent of Zyflamend, Inhibits Aryl Hydrocarbon Receptor-Mediated Activation of CYP1A1 and CYP1B1 Transcription and Mutagenesis.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: June 02, 2022
Anaplastic thyroid carcinoma: a 25-year single-institution experience.
Journal: Annals of surgical oncology
Published: October 24, 2013
Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: May 18, 2013
Parathyroid carcinoma: challenges in diagnosis and treatment.
Journal: Hematology/oncology clinics of North America
Published: November 03, 2012
The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma.
Journal: Annals of surgical oncology
Published: March 14, 2012
A web-based screening and accrual strategy for a cancer prevention clinical trial in healthy smokers.
Journal: Contemporary clinical trials
Published: March 09, 2012
Carnosol, a constituent of Zyflamend, inhibits aryl hydrocarbon receptor-mediated activation of CYP1A1 and CYP1B1 transcription and mutagenesis.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: March 01, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026